Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
URGE: Fesoterodine Pharmacogenetics in Elderly Women with UUI
NCT01786967Phase 3Completed
- Sponsor
- University of North Carolina at Chapel Hill
- Start
- Sep 2012
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of fesoterodine in urge urinary incontinence (UUI), sponsored by University of North Carolina at Chapel Hill. Started Sep 2012; status: completed.
02
Drugs
fesoterodine
03
Conditions
urge urinary incontinence (UUI)
Beyond the preview
Go deeper on NCT01786967.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01786967.